Drugs / Clarythromycin
last change Sep 2016 re-read 2 minutes ago

Clarythromycin

Developed for
Helicobacter pylori infectious disease · bacterial pneumonia · chronic bronchitis
Investigated by
EMS

Trials 1 · a red edge is where a trial was stopped

20162017201820192020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT02552641 Sep 2015 → Feb 2016 Helicobacter pylori infectious disease EMS Withdrawn No outcome recorded
Also used as a comparator or background therapy in 2 trials
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT00713947 Comparator Apr 2008 → Mar 2009 coronary thrombosis Assistance Publique - Hôpitaux de Paris Withdrawn No outcome recorded
Phase 4 NCT00245453 Comparator Oct 2005 → Jul 2006 bacterial pneumonia, chronic bronchitis CPL Associates Withdrawn No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 3 sources stand behind the page.

FieldValueCited text
Known as Clarythromycin “Amoxicillin, Clarythromycin or metronidazole,Pantoprazole,Placebo” NCT00713947
2

NCT02552641

NCT00245453